Skip to Main Content

Tow Foundation Commits $2 Million To Multiple Myeloma Research At Sylvester

Driving Research For Patients

Kristin E. Rojas, M.D., F.A.C.S.
Emily Tow and Dr. Leonard Tow. Photo by Rich Freeda

The donation is a testament to the work of C. Ola Landgren, M.D., Ph.D., a world-renowned hematologic oncologist.

The Tow Foundation has committed $2 million to support multiple myeloma research at Sylvester Comprehensive Cancer Center, a part of UHealth – University of Miami Health System, and in particular, the work of C. Ola Landgren, M.D., Ph.D., a world-renowned hematologic oncologist.

“This donation is a testament to the extraordinary vision, leadership and expertise of Dr. Landgren and the entire myeloma team here at Sylvester,” said Stephen D. Nimer, M.D., director of Sylvester.

This donation is the first of its kind for the foundation, as philanthropic efforts, up to now, were focused in New York and Connecticut, where it is based. The decision to support a cancer institution outside of this region was based on the foundation’s confidence in Dr. Landgren.

The relationship began several years ago, when Leonard Tow, Ph.D., founder of the Tow Foundation, met Dr. Landgren when he was a faculty leader at Memorial Sloan Kettering in New York. “I’ve met many rather esteemed scientists, but his style was completely different,” said Dr. Tow. “Dr. Landgren does not accept anything less than success, and I don’t doubt for a moment that he’s on the trail to accomplish something with this multiple myeloma research.”

Dr. Tow and his wife, Claire, established the Tow Foundation in 1988, to fund projects that offer transformative experiences to individuals and create collaborative ventures in fields where they see opportunities for breakthroughs, reform and benefits for underserved populations.